Dr. Joel MD

05/18/2026

05/16/2026

Your health coach has a conflict of interest. I don’t.
Most “metabolic health” influencers profit on every supplement, powder, and protocol they push. I’m a physician. I get paid the same whether I prescribe nothing or a hundred prescription medications. Ask yourself who actually benefits from the advice you’re following.

05/06/2026

Get your Executive Healthspan Score (Link in bio)

Heart disease is a silent process. You can be lean, active, metabolically healthy appearing, and still carry significant cardiovascular risk beneath the surface.

One of the most important markers I monitor in myself and my patients is ApoB, which reflects the total number of atherogenic particles capable of penetrating the arterial wall and driving plaque formation over time.

Genetics play a massive role. My grandfather had a heart attack at 38, and despite prioritizing fitness and nutrition for years, I still had elevated ApoB that required aggressive intervention.

This is why objective data matters.

Through lifestyle optimization and targeted pharmacotherapy, my ApoB is now 46 mg/dL, a level associated with extremely low long-term cardiovascular risk and slowed plaque progression.

Most people are never told to check ApoB. They are simply told their “cholesterol looks fine.”

That is not enough.

The earlier you identify risk, the more preventable heart disease becomes.

05/05/2026

The most underappreciated organ in medicine is your skeletal muscle.

Most physicians don’t measure it. Most insurance won’t cover testing for it. Most patients don’t know they’re losing it until something breaks.

Here’s what the data actually shows:

🔬 HIP FRACTURE MORTALITY
One-year mortality after a hip fracture in adults over 65 averages 22% globally. The fracture isn’t what kills them — it’s the cascade that follows: pneumonia, blood clots, delirium, deconditioning.

🔬 SARCOPENIA STARTS EARLY
Muscle mass declines 3–8% per decade after age 30. Strength declines faster — up to 50% by age 80. The patients who survive falls are the ones who had muscle to spare.

🔬 MUSCLE IS AN ENDOCRINE ORGAN
When you contract muscle, it releases myokines — hormone-like molecules that lower inflammation, improve insulin sensitivity, support brain health, and protect your heart and bones.

🔬 THE GLUCOSE STORY
After a meal, ~80% of glucose is taken up by skeletal muscle. Lose muscle, lose your primary glucose buffer. This is why sarcopenia and insulin resistance travel together.

🔬 WHAT ACTUALLY BUILDS MUSCLE
No medication, peptide, or IV replaces these three:

1. Progressive resistance training (2–3x/week, near failure, progressive load)
2. Adequate protein (1.6–2.2 g/kg/day, 30–40g per meal)
3. Deep restorative sleep (7–9 hours, prioritize slow-wave sleep)

🔬 THE BOTTOM LINE
Low muscle mass is one of the strongest predictors of all-cause mortality we have — and one of the most reversible. Eighty-year-olds grow new muscle in 12 weeks of resistance training.

Muscle isn’t aesthetic. Muscle is survival.

Save this. Send it to someone you love.

— Dr. Joel Wussow
Preventive & Emergency Medicine Physician
Healthspan by Design

05/04/2026

Most peptides being used today never made it through proper human trials.

They exist in:
• petri dish studies
• animal studies

And sometimes:
• limited or abandoned human trials

That’s not proof of effectiveness.

And it’s not enough to establish safety.

If something hasn’t been tested in well-designed human trials, you don’t know:
• what dose works
• what the risks are
• or if the benefits are even real

That’s not treatment.

That’s experimentation.

04/29/2026

04/28/2026

Patients ask me about peptides every week. BPC-157. TB-500. Ipamorelin. The list keeps growing.
Before I’d ever recommend one or take it myself it has to pass 4 questions:

Do we know how it actually works in the human body?
Has it been proven in real humans, not rats or cells?
Do we know the right dose from actual studies?
Do we know it’s safe long-term?

Semaglutide (Ozempic, Wegovy) passes. Most of what’s being marketed online doesn’t come close.
If you can’t answer all 4 you’re not on a treatment.
You’re running an experiment on yourself.

Save this. Send it to the friend who’s about to start.

Visit healthspanbydesign.co if you want to learn how to truly optimize your health

04/27/2026

Peptides aren’t the problem.

👉 Bad evidence is.

There are peptide-based drugs that are well-studied and widely used—like
Semaglutide—with strong human data and known safety.

Then there are the peptides most people are talking about online.

And those typically have:
• no high-quality human trials
• no long-term safety data
• no validated dosing

A common argument is:
👉 “They aren’t being studied because they can’t be patented.”

That’s simply not true.

Most peptides—whether approved or experimental—are not in their natural form.

👉 They are analogs.

They’ve been:
• modified
• stabilized
• engineered

And that makes them:
👉 patentable
👉 scalable
👉 profitable

So if one of these peptides truly delivered consistent, meaningful results…

👉 pharma would be all over it

That’s not speculation—that’s how the system works.

So when something remains in the gray zone for years…

👉 the more likely explanation is that it hasn’t held up when tested

Not that it’s being ignored.

01/09/2026

Entrenando duro porque este año hay boda 😆🙈👰🏽🤵🏻‍♂️🤞🏽 💒💍

Your longevity Doctor & your Registered Dietitan practice what they preach 🩺🥗

01/07/2026

The new Dietary Guidelines push more animal foods and higher protein intake.
Some of that makes sense.

But the same guidelines still recommend keeping saturated fat under 10% of total calories, which is very hard to do on a diet built around steak, eggs, whole milk, butter, and full-fat dairy.

Saturated fat adds up quickly.
Excess intake raises LDL and ApoB, and elevated ApoB is causal for cardiovascular disease.

Eating more quality protein is a good idea.
But what you choose matters if you want to reduce long-term risk.

When nutrition advice sends mixed signals, the math needs to be explained clearly, not brushed off as “old dogma.”

Citations:
• Ference BA et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. Eur Heart J. 2017.
• Ference BA et al. Association of genetic variants related to LDL-C with cardiovascular disease. JAMA. 2016.
• Mensink RP et al. Effects of saturated fatty acids on serum lipids and lipoproteins. Am J Clin Nutr. 2003.
• Clarke R et al. Apolipoprotein B and cardiovascular risk. JAMA. 2020.
• JAMA Network Open. 2021. Ultra-processed food intake in U.S. children

01/06/2026

Watching Peter Attia give rapid-fire longevity takes and pausing where context matters.

• Rapamycin shows its strongest human signal in older adults, mainly immune function. Not proven for younger, healthy people.
• Microplastics matter, but hot exposure is the bigger issue.
• Hormone therapy is still widely misunderstood.
• Testosterone, when used correctly, can be transformative. For women, it is often the most effective treatment for low libido, even when labs look “normal.”

Big levers. Real data. Context over hype.

Educational only. Not medical advice.